NKTX

Nkarta, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Hastings Paul JDirector, Officer: Chief Executive Officer
$54k26k shares
SellJan 15, 2026
$2.07
--
Mahmood NadirPresident
$12k5.6k shares
SellJan 15, 2026
$2.07
--
Hastings Paul JDirector, Officer: Chief Executive Officer
$3.2k1.8k shares
SellJun 18, 2025
$1.79
--
Hastings Paul JDirector, Officer: Chief Executive Officer
$38k17.4k shares
SellJan 15, 2025
$2.20
--
Brandenberger RalphChief Technical Officer
$16k7.4k shares
SellJan 15, 2025
$2.20
--
Hager Alicia J.Chief Legal Officer
$21k9.6k shares
SellJan 15, 2025
$2.20
--

News

prnewswire.comThe $13 Million Company Teaching the Immune System to Hunt Cancerprnewswire.comMay 29globenewswire.comNkarta Reports First Quarter 2026 Financial Results and Corporate Highlightsglobenewswire.comMay 12zacks.comNKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Programzacks.comApr 17globenewswire.comNkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centersglobenewswire.comApr 15globenewswire.comNkarta to Participate in Needham Virtual Healthcare Conferenceglobenewswire.comApr 9